Your search history is turned on.
Date: February 19, 2019 Jurisdictions: British Columbia, Ontario
Ontario Securities Commission Commission des valeurs mobilires de lOntario 22nd Floor 20 Queen Street West Toronto ON M5H 3S8 22e tage 20, rue Queen ouest Toronto ON M5H 3S8 OSC NOTICE TO PUBLIC ISSUER: Nexien BioPharma Inc. Principal Jurisdiction - Ontario DATES: Amendment to Preliminary Long Form Prospectus dated November 21, 2018 Withdrawn on February 19, 20...
Date: November 22, 2018 Jurisdictions: British Columbia, Ontario
Microsoft Word - Preliminary Prospectus - Nexien - revised 4831-3127-0777 v.12.docx A copy of this amended and restated preliminary prospectus has been filed with the securities regulatory authorities in each of the provinces of Ontario and British Columbia but has not yet become final. Information contained in this amended and restated preliminary prospectus may not b...
Ontario Securities Commission Commission des valeurs mobilires de lOntario 22nd Floor 20 Queen Street West Toronto ON M5H 3S8 22e tage 20, rue Queen ouest Toronto ON M5H 3S8 RECEIPT Nexien BioPharma Inc. This is the receipt of the Ontario Securities Commission for the Amended and Restated Preliminary Long Form Prospectus dated November 21, 2018 (the amended prelim...
Date: August 23, 2018 Jurisdictions: British Columbia, Ontario
Feb 25 2008 13:59 PRRK R VENUE GROUP 2 1 2S589867 p. 3 State of Delaware ' of State . Corporations Delivered 01:54 PM 02/25/2008 FILED 01 :54 PM 02/25/2008 SRV 080215336 - 4509575 FILE Secretary Division of t STATE o/DELEWARE CERTIFICATE o/ INCORPORATION A STOCK CORPORATION Article I The ri2me ofthe Corporation is GANTOS, INC. Article EL The Corporation's regis...
12/28/2017 Exhibit 3.2 https://www.sec.gov/Archives/edgar/data/1625288/000085698414000011/exh3_2.htm 1/8 EX-3 6 exh3_2.htm EXHIBIT 3.2 TABLE OF CONTENTS Article Subject ARTICLE I OFFICES Section 1 Principal Office Section 2 Other Office ARTICLE II MEETINGS OF STOCKHOLDERS Section 1 Place of Meetings Section 2 Time and Notice of Annual Meetings Section 3 S...
EXCLUSIVE LICENSE AGREEMENT THIS EXCLUSIVE LICENSE AGREEMENT (the Agreement), effective as of this 28 day of February, 2018, between ACCU-BREAK PHARMACEUTICALS, INC., a Florida corporation having a business address of 6100 Hollywood Boulevard, Suite 207, Hollywood, FL 33024 (the Licensor) and INTIVA BIOPHARMA INC., a Delaware corporation having a busin...
Microsoft Word - Preliminary Prospectus - Intiva BioPharma Inc. - SEDAR Conformed - August 22, 2018 4823-1145-3296 v.1.docx A copy of this preliminary prospectus has been filed with the securities regulatory authorities in each of the provinces of Ontario and British Columbia but has not yet become final. Information contained in this preliminary prospectus may not be ...
Amended and Restated Share Exchange Agreement by and between Kinder Holding Corp. and Intiva BioPharma Inc. Dated as of October 13, 20...
ACTIVE\44870702.v1-3/17/17 ACTIVE\44877120.v1-3/20/17 ACTIVE\44870702.v3-3/27/17 EXCLUSIVE LICENSE AGREEMENT THIS EXCLUSIVE LICENSE AGREEMENT (the Agreement), effective as of this 29th day of March, 2017, between KOTZKER CONSULTING LLC, a Delaware limited liability company having a business address of 20 Highview Ln, Yardley, PA 19067 (the LICENSO...
Ontario Securities Commission Commission des valeurs mobilires de lOntario 22nd Floor 20 Queen Street West Toronto ON M5H 3S8 22e tage 20, rue Queen ouest Toronto ON M5H 3S8 RECEIPT Intiva BioPharma Inc. This is the receipt of the Ontario Securities Commission for the Preliminary Long Form Prospectus of the above Issuer dated August 22, 2018 (the preliminary prosp...